Rare diseases
Investigational molecules
Locations
Back to Latvia45 clinical trials in Liepaja, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LatviaKliniskiePetijumi.lv(opens in a new tab)Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
LatviaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
LatviaStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
LatviaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
LatviaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
LatviaStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
LatviaStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
LatviaLong‑Term Follow‑Up of Mitomycin (UGN‑103) Treatment in Patients with Recurrent Low‑Grade Intermediate‑Risk Non‑Muscle Invasive Bladder Cancer
LatviaComparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery
LatviaSafety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder
LatviaStudy of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer
LatviaEvaluating NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder Who Are Not Responding Adequately to Current Therapy
LatviaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on treatments for psoriatic arthritis, ulcerative colitis, and systemic lupus erythematosus. Studies evaluate novel therapies including zasocitinib, eltrekibart, and upadacitinib for improved disease management.
Research aims to enhance treatment efficacy and patient outcomes in chronic inflammatory conditions.
Innovative studies targeting atherosclerotic cardiovascular disease and stroke prevention. Trials examine new medications like inclisiran and asundexian for managing cardiovascular risks and preventing major adverse events.
Focus on reducing cardiovascular events and improving patient outcomes in high-risk populations.
Research investigating treatments for bladder cancer and prostate cancer. Clinical trials evaluate innovative therapies including UGN-102 and novel combinations for various stages of cancer progression.
Studies aim to improve treatment options and outcomes for cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
